Management of an Acinetobacter baumannii outbreak in an intensive care unit;Prise en charge d'une épidémie à Acinetobacter baumannii en service de réanimation médicale

Medecine et Maladies Infectieuses

Volumn 47, Issue 6, 2017, Pages 409-414

  Tanguy, M ^a   Kouatchet, A ^b   Tanguy, B ^c   Pichard, E ^b   Fanello, S ^b   Joly Guillou, M L ^b  

^a UNIVERSITÉ DE LORRAINE   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c CHU d'Angers ^*  (Reunion)

Author keywords

Acinetobacter baumannii; Bacterial resistance; Intensive care unit; Outbreak

Indexed keywords

BETA LACTAM ANTIBIOTIC; QUINOLINE DERIVED ANTIINFECTIVE AGENT; HYDROGEN PEROXIDE; TOPICAL ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM DETECTION; BACTERIUM ISOLATION; CLINICAL ARTICLE; CLINICAL EVALUATION; DRUG EFFECT; EPIDEMIC; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ACINETOBACTER BAUMANNII; HAND WASHING; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; MULTIDRUG RESISTANCE; NONHUMAN; TREATMENT PLANNING; ADOLESCENT; AGED; CROSS INFECTION; DISINFECTION; EVALUATION STUDY; FRANCE; LENGTH OF STAY; MICROBIOLOGY; MIDDLE AGED; PHYSICIAN ORDER ENTRY SYSTEM; PROCEDURES; UNIVERSITY HOSPITAL; VERY ELDERLY; YOUNG ADULT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS, LOCAL; CROSS INFECTION; DISEASE OUTBREAKS; DISINFECTION; DRUG RESISTANCE, MULTIPLE; FRANCE; HOSPITALS, UNIVERSITY; HUMANS; HYDROGEN PEROXIDE; INTENSIVE CARE UNITS; LENGTH OF STAY; MEDICAL ORDER ENTRY SYSTEMS; MIDDLE AGED; YOUNG ADULT;

EID: 85024915886     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2017.06.003     Document Type: Article

References (12)

1. Antunes, L., Visca, P., Towner, K., Acinetobacter baumannii: evolution of a global pathogen. Pathog Dis 71:3 (2014), 292–301.
2. Naas, T., Coignard, B., Carbonne, A., et al. VEB-1 extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France. Emerg Infect Dis 12 (2006), 1214–1222.
3. Vaux, S., et al. Signalement des infections nosocomiales à Acinetobacter baumannii résistant à l'imipénème, France, août 2001–mai 2011. Bull Epid Heb, 2012, 31–32.
4. Ministère de la santé de la jeunesse et des sports, Actualisation de la définition des infections nosocomiales. Ministère de la santé de la jeunesse et des sports. 2007, DGS/DHOS, CTINILS, mai 2007.
5. Grammatico-Guillon, L., et al. Relationship between the prevalence of methicillin resistant staphylococcus aureus infection and indicators of nosocomial infection control measures: a population based study in French hospitals. Infect Control Hosp Epidemiol 30 (2009), 861–869.
6. Pittet, D., Hugonnet, S., Harbarth, S., Mourouga, P., et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet 356 (2000), 1307–1312.
7. Flandrois, J.P., Acinetobacter baumannii: Bactériologie médicale collection. 1997, Azay, Presse. universitaire de Lyon, 210–212.
8. Levin, A.S., Gobara, S., Mendes, C.M., Cursino, M.R., Sinto, S., Environmental contamination by multidrug-resistant Acinetobacter baumannii in an intensive care unit. Infect Control Hosp Epidemiol 22:11 (2001), 717–720.
9. Falagas, M., Rafailidis, P., Attributable mortality of Acinetobacter baumannii: no longer a controversial issue. Crit Care 11:3 (2007), 134–137.
10. Falagas, M., Bliziotis, I., Siempos, I., Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies. Crit Care, 10, 2006, R48.
11. Naas, T., Fortineau, N., Nordmann, P., Diffusion de Acinetobacter baumannii multirésistant dans les établissements de santé: situation actuelle en France et mesures de contrôle. Hygienes 6 (2008), 481–491.
12. Kac, G., Grohs, P., Durieux, P., Trinquart, L., Gueneret, M., Rodi, A., et al. Impact of electronic alerts on isolation precautions for patients with multidrug-resistant bacteria. Arch Intern Med 167:19 (2007), 2086–2090.